Parkinson's Disease/Parkinson syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Aged >= 30 years,<= 75 years; No restrictions on men or women; 2) According to the diagnostic criteria of MDS primary Parkinson's disease, the diagnosis is clinically confirmed Parkinson's disease or clinically probable Parkinson's disease;or diagnosis is parkinson syndrome. 3) The H-Y 1-4; 4) Patients who take anti-Parkinson drugs for more than one month with stable symptoms and do not need drug adjustment in the short term; 5) The patient agrees to conduct the study and signs the informed consent.
Exclusion criteria
Exclusion criteria: 1) Those using beta blockers; 2) Users of anti-psychotropic drugs; 3) With heart disease, (including but not limited to, unstable angina, myocardial infarction, arrhythmia, uncontrolled high blood pressure), respiratory disease, (including but not limited to, COPD, asthma, emphysema, etc.), nervous system diseases (including but not limited to, cerebrovascular diseases, etc.), bone (including but not limited to, joint replacement surgery, severe osteoporosis, etc.), such as serious complications, are contraindications to rehabilitation training; 4) Severe visual, hearing, or cognitive impairment (MMSE & LT < 24 points), unable to cooperate with the assessment task; 5) Patients with uncontrolled epilepsy, central nervous system disease, mental disorder or malignant tumor history, whose clinical severity is judged by the researcher to affect the compliance of the clinical study; 6) Unable to use the Smart phone or Internet.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PQD-39; | — |
Secondary
| Measure | Time frame |
|---|---|
| MDS-UPDRS;Levodopa Equivalent dose;Healthcare burden (Healthcare costs); | — |
Countries
China
Contacts
Beijing Rehabilitation Hospital, Capital Medical University